Loading...
Loading...
Analysts at SunTrust Robinson Humphrey upgraded
CVS Health CorporationCVS to Buy.
The price target for CVS Health is set to $110.
CVS Health shares have gained 36.34% over the past 52 weeks, while the S&P 500 index has surged 13.36% in the same period.
CVS Health's shares rose 0.45% to $95.95 in pre-market trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
